A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...
Add Yahoo as a preferred source to see more of our stories on Google. Over the last several days, the safety and efficacy of messenger RNA, or mRNA, vaccines have come under intense scrutiny. On ...
Morning Overview on MSN
An mRNA vaccine paired with Keytruda cut melanoma recurrence by nearly 50% over five years in a landmark NYU-led trial
Patients with high-risk melanoma who received a personalized mRNA cancer vaccine alongside pembrolizumab after surgery saw ...
StockStory.org on MSN
Why is Moderna (MRNA) stock rocketing higher today?
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 5.1% in the afternoon session after the stock's ...
The U.S. helped pioneer the technology, but new funding cuts may shift breakthroughs — and industry leadership — overseas.
Melanoma is one of the most common types of cancer in the United States, with the American Cancer Society predicting 104,960 new cases and 8,430 deaths in 2025. But scientists at Moderna and Merck are ...
SAN ANTONIO – The federal government’s decision to slash $500 million in funding for mRNA vaccine research has sparked concern among health experts. “The news that we’re going to block a Nobel ...
On first glance, the data that Health and Human Services Secretary Robert F. Kennedy Jr. cited to justify canceling some $500 million in federal grants for mRNA vaccine research looked impressive. The ...
On Sept. 4, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. is scheduled to testify before the Senate Finance Committee, where he is expected to face questions about his vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results